Expert consensus on prescribing restrictions that prevent primary care providers (PCPs) in Europe from initiating single-inhaler triple therapy (SITT)
Chronic Obstructive Pulmonary Disease (COPD) is a progressive condition that places a significant burden on patients and healthcare systems. Guidelines recommend triple therapy for patients with moderate-to-severe COPD whose disease remains inadequately controlled despite receiving dual therapy. This can be delivered either via multiple inhalers (MITT) or a single inhaler (SITT). SITT has been shown Read More >